Table 4.
Variants with unclear causal significance for ALS
Patient characteristics | Gene | Inheri-tance | Reference sequence | DNA variant | Protein change | Allele frequency gnomAD v2.1.1 | dbSNP | ACMG criteria | ACMG classification | ClinVar | PolyPhen-2 | SIFT | CADD | Splice Al | Ref. | |||
Sex | Age of onset | Disease subtype | fALS | |||||||||||||||
F | 59 | Spinal ALS | no | FIG4 L | AD | NM_014845.6 | c.122T > C | p.(Ile41Thr) | 1.0 e–3 | rs121908287 | PM3vstr, PS3sup, PM2mod |
Pathogenic | Pathogenic | D (1) | D (0) | 25,8 | B (0) | [21] |
M | 29 | Spinal ALS | no | FIG4 L | AD | NM_014845.6 | c.2095C > T | p.(Arg699Cys) | 3.54 e–5 | rs764799053 | PM2mod, PP3sup |
Uncertain | Uncertain | U (0.96) | D (0) | 33 | B (0.01) | [5] |
F | 59 | Spinal+ FTD | no | KIF5A | AD | NM_004984.4 | c.291 + 5G > A | N/A | 1.2 e–5 | rs775732465 | PM2mod, PP3sup |
Uncertain | Uncertain | N/A | N/A | N/A | M (0.33) | [22] |
NG_088155.1 | g.18635G > A | |||||||||||||||||
M | 50 | Bulbar | no | NEFH S | AD | NM_021076.4 | c.1084-3C > G | N/A | 1.2 e–5 | rs1347201784 | PM2mod, PP3sup | Uncertain | - | N/A | N/A | N/A | S (0.55) | – |
NG_008404.1 | g.10529C > G | |||||||||||||||||
M | 59 | Bulbar | no | NEK1 S | AD | NM_001199397.3 | c.760G > T | p.(Glu254*) | 0 | – | PVS1mod, PM2mod | Uncertain | - | N/A | N/A | N/A | S (0.55) | – |
F* | 64 | Bulbar+ FTD | no | OPTN | AR | NM_001008212.2 | c.785C > A | p.(Ser262*) | 1.42 e–5 | rs750571210 | PM3str, PVS1vstr, PM2mod, PP5 |
Pathogenic | Pathogenic | N/A | N/A | N/A | B (0) | [23] |
F* | 41 | Bulbar | yes | OPTN | AR | NM_001008212.2 | c.785C > A | p.(Ser262*) | 1.42 e–5 | rs750571210 | PM3str, PVS1vstr, PM2mod, PP5 |
Pathogenic | Pathogenic | N/A | N/A | N/A | B (0) | [23] |
F | 38 | Spinal ALS | no | SETX L | AD | NM_015046.7 | c.4796T > C | p.(Phe1599Ser) | 0 | – | PM2mod | Uncertain | – | D (0.99) | D (0) | 26,8 | B (0) | – |
M | 64 | Spinal ALS | no | SETX L | AD | NM_015046.7 | c.6865T > C | p.(Ser2289Pro) | 0 | – | PM2mod | Uncertain | – | D (0.99) | U (0.025) | 24,5 | B (0) | – |
F** | 37 | LMN- predomin. | no | SOD1 | AD/AR | NM_000454.5 | c.378C > G | p.(Asp126Glu) | 0 | – | PM1mod, PP2sup, PM2mod, PM5sup, PP3sup, |
Likely pathogenic | - | D (0.99) | D (0) | 25,5 | B (0.03) | – |
TARDBP | AD | NM_007375.4 | c.169G > A | p.(Val57Ile) | 0 | – | PM2mod, PP2sup | Uncertain | – | B (0.03) | B (0.7) | 21 | B (0) | – | ||||
F | 57 | Spinal | no | SPAST | AD | NM_014946.4 | c.8C > T | p.(Ser3Phe) | 0 | – | PM2mod, PP2sup |
Uncertain | – | D (0.98) | D (0) | 23,4 | B (0.03) | – |
M | 64 | Bulbar | no | SPG11 | AR | NM_025137.4 | c.2757_2775 del | p.(Leu920Thrfs*10) | 0 | rs1595888828 | PVS1vstr, PM3str, PM2mod, PP5 |
Pathogenic | Likely Pathogenic | N/A | N/A | N/A | B (0) | – |
M | 60 | LMN- predomin. | no | SPG11 | AR | NM_025137.4 | c.3075dup | p.(Glu1026Argfs*4) | 2.79 e–5 | rs312262752 | PVS1vstr, PM3vstr, PM2mod, PP1sup PP5 |
Pathogenic | Pathogenic | N/A | N/A | N/A | B (0.06) | [24], [25] |
M | 29 | Spinal ALS | no | TBK1 | AD | NM_013254.4 | c.2069T > C | p.(Met690Thr) | 0 | – | PM2mod | Uncertain | – | D (0.9) | D (0.1) | 24,9 | B (0.02) | – |
F | 70 | Bulbar | no | UBQLN2 | XLD | NM_013444.4 | c.1481C > T | p.(Pro494Leu) | 0 | – | PM2mod | Uncertain | – | B (0.02) | B (0) | 22,2 | B (0) | [26] |
All listed variants are heterozygous; LMN – lower motor neuron; * marks 2 related individuals, mother and daughter – the mother was classified as sporadic at the time of inclusion (ad hoc), the daughter developed disease 2 years later; ** marks a single patient, carrying simultaneously 2 variants (in SOD1 and TARDBP); GeneL – limited association with ALS; GeneS – confers susceptibility to ALS; AR – autosomal recessive; XLD – X-linked dominant; Allele frequency gnomAD v2.1.1 shows the aggregated frequency in The Genome Aggregation Database; dbSNP, Single Nucleotide Polymorphism Database reference SNP ID number for the variant; ACMG criteria; ACMG, The American College of Medical Genetics and Genomics; ClinVar – public archive of reports of the relationships among human genetic variations and phenotypes, with supporting evidence, PolyPhen-2 – an automatic tool for prediction of the possible impact of an amino acid substitution on the structure and function of a human protein; SIFT – The Sorting Intolerant from Tolerant (SIFT) algorithm predicts the effect of coding variants on protein function; CADD – the Combined Annotation Dependent Depletion for scoring the deleteriousness of single nucleotide variants, multi-nucleotide substitutions as well as insertion/deletion variants in the human genome, the lower the score, the more benign the substitution; SpliceAl, a deep learning splicing predictor algorithm; D, deleterious; U, uncertain; B, benign; M, moderate; S, strong; N/A, not applicable; ACMG criteria: pathogenic vstr – very strong, str – strong, sup – supporting, mod – moderate.